FINKELSTEIN J J
Insider CIK 1125610 · RGRX President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2022-05-17 | 2022-05-19 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2021-08-02 | 2021-08-04 | 600,000 | — | $0 | 600,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2021-06-30 | 2021-07-06 | 56,250 | — | $0 | 56,250 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2021-06-30 | 2021-07-06 | 56,250 | — | $0 | 56,250 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy | 2021-06-30 | 2021-07-06 | 75,000 | $0.20 | $15.0K | 1,712,991 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2020-10-15 | 2020-10-20 | 20,880 | $10000.00 | $208.80M | 20,880 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2020-10-15 | 2020-10-20 | 0 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2020-06-10 | 2020-06-12 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2019-05-15 | 2019-05-17 | 650,000 | — | $0 | 650,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2019-05-13 | 2019-05-15 | 78,125 | $12500.00 | $976.56M | 78,125 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2019-05-13 | 2019-05-15 | 0 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2019-02-27 | 2019-03-01 | 0 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | P Buy deriv | 2019-02-27 | 2019-03-01 | 78,125 | $12500.00 | $976.56M | 78,125 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2018-07-17 | 2018-07-19 | 250,000 | $0.21 | $52.5K | 250,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | C Conversion deriv | 2018-07-05 | 2018-07-09 | 104,456 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | C Conversion | 2018-07-05 | 2018-07-09 | 104,456 | $0.06 | $6.3K | 1,637,991 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | C Conversion deriv | 2017-10-19 | 2017-10-20 | 125,347 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | X Exercise deriv | 2017-10-19 | 2017-10-20 | 20,000 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | C Conversion | 2017-10-19 | 2017-10-20 | 125,347 | $0.15 | $18.8K | 1,513,535 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | X Exercise | 2017-10-19 | 2017-10-20 | 20,000 | $0.15 | $3.0K | 1,533,535 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2017-09-01 | 2017-09-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2016-03-16 | 2016-03-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2015-06-30 | 2015-07-02 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2014-09-29 | 2015-02-13 | 0 | $15000.00 | $0 | 100,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | D To issuer deriv | 2014-09-29 | 2015-02-13 | 0 | $15000.00 | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2014-03-25 | 2014-04-01 | 500,000 | — | $0 | 500,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2013-07-05 | 2013-10-11 | 0 | $5000.00 | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2012-10-19 | 2012-10-23 | 20,000 | $15000.00 | $300.00M | 20,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2012-10-19 | 2012-10-23 | 0 | — | $0 | 0 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2012-04-03 | 2012-04-05 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RGRX REGENERX BIOPHARMACEUTICAL | A Award deriv | 2012-01-24 | 2012-01-26 | 500,000 | — | $0 | 500,000 | SEC↗ |